Literature DB >> 16076371

Hemoperfusion with an immobilized polymyxin B fiber column inhibits activation of vascular endothelial cells.

Hidehiko Kushi1, Jun Nakahara, Takahiro Miki, Kazuhiko Okamoto, Takeshi Saito, Kastuhisa Tanjo.   

Abstract

Involvement of the activation of neutrophils and vascular endothelial cells in the pathology of sepsis has recently been reported. We therefore investigated whether direct hemoperfusion (DHP) with a polymyxin B immobilized fiber column (PMX) could reduce the level of plasminogen activator inhibitor-1 (PAI-1), an index of vascular endothelial cell activation. Twelve sepsis patients satisfying the following criteria were enrolled in the study: (i) stable global oxygen metabolism (oxygen delivery index>500 mL/min/m2 and oxygen consumption index>120 mL/min/m2); (ii) abnormal tissue oxygen metabolism (PCO2 gap: gastric mucosal PCO2 minus arterial PCO2 difference>8 mm Hg); and (iii) mean blood pressure>or=60 mm Hg. Direct hemoperfusion with PMX was performed twice (for 3 h each time) within 24 h. Plasminogen activator inhibitor-1 was measured a total of 5 times: before PMX-DHP, immediately after the first DHP with PMX session (3 h after the start), and 24, 48, and 72 h afterward. The PAI-1 value was 150+/-30.0 ng/mL before DHP with PMX, 178+/-60.0 ng/mL immediately after DHP with PMX, 90+/-22.1 ng/mL at 24 h after, 65+/-21.0 ng/mL at 48 h after, and 64+/-18.3 ng/mL 72 h after. The values were significantly lower from 48 h onward compared with baseline. These data suggest that DHP with PMX inhibits vascular endothelial cell activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16076371     DOI: 10.1111/j.1744-9987.2005.00286.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  6 in total

1.  Direct hemoperfusion with a polymyxin B-immobilized cartridge in intestinal warm ischemia reperfusion.

Authors:  Hiroaki Sato; Kiyohiro Oshima; Kazuhisa Arakawa; Katsumi Kobayashi; Hodaka Yamazaki; Yujin Suto; Izumi Takeyoshi
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

2.  Hemoperfusion with polymyxin B-immobilized fiber column improves liver function after ischemia-reperfusion injury.

Authors:  Hiroaki Sato; Kiyohiro Oshima; Katsumi Kobayashi; Hodaka Yamazaki; Yujin Suto; Izumi Takeyoshi
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

3.  Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation.

Authors:  Hidehiko Kushi; Takahiro Miki; Kazuhiko Okamaoto; Jun Nakahara; Takeshi Saito; Katsuhisa Tanjoh
Journal:  Crit Care       Date:  2005-10-11       Impact factor: 9.097

4.  Treatment of acute exacerbation of idiopathic pulmonary fibrosis with direct hemoperfusion using a polymyxin B-immobilized fiber column improves survival.

Authors:  Noriyuki Enomoto; Masashi Mikamo; Yoshiyuki Oyama; Masato Kono; Dai Hashimoto; Tomoyuki Fujisawa; Naoki Inui; Yutaro Nakamura; Hideo Yasuda; Akihiko Kato; Soichiro Mimuro; Matsuyuki Doi; Shigehito Sato; Takafumi Suda
Journal:  BMC Pulm Med       Date:  2015-02-22       Impact factor: 3.317

5.  Effectiveness of polymyxin B hemoperfusion in acute exacerbation of interstitial pneumonia: a retrospective analysis.

Authors:  Song-I Lee
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2021-03-31       Impact factor: 0.670

Review 6.  Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review.

Authors:  Dinna N Cruz; Mark A Perazella; Rinaldo Bellomo; Massimo de Cal; Natalia Polanco; Valentina Corradi; Paolo Lentini; Federico Nalesso; Takuya Ueno; V Marco Ranieri; Claudio Ronco
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.